We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£142.89
This is the most expensive it has ever been. Walk away.
£143 today · previous high £143 · all-time low £136
Elsevier Biology of T Cells - Part A (Volume 341) (International Review of Cell and Molecular Biology, Volume 341)
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 62 days · 62 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 62 days • 2 price levels
Price Analysis
Most common price: £143 (60 days, 96.8%)
Price range: £136 - £143
Price levels: 2 different prices over 62 days
Description
Product Specifications
- Brand
- Elsevier
- Format
- hardcover
- ASIN
- 0128153857
- Domain
- Amazon UK
- Release Date
- 02 October 2018
- Listed Since
- 16 March 2018
Barcode
No barcode data available
Similar Products You Might Like
Biology of T Cells - Part B: Volume 342 (International Review of Cell and Molecular Biology, Volume 342)
Elsevier
Academic Press Tumor Immunology and Immunotherapy Vol 636
Elsevier
Tumor Immunology and Immunotherapy - Integrated Methods Part A: Volume 635 (Methods in Enzymology, Volume 635)
Elsevier
Tumor Immunology and Immunotherapy – Cellular Methods Part A (Volume 631) (Methods in Enzymology, Volume 631)
Elsevier
Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)
Springer
Clinical Immuno-Oncology
Elsevier
Immunotherapy in Translational Cancer Research (Translational Oncology)
Wiley
Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance
Elsevier
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
Humana
Cancer Immunotherapy: Immune Suppression and Tumor Growth
Elsevier
Cancer Immunotherapy: Immune Suppression and Tumor Growth
Elsevier
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
Springer
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
Springer
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
Humana
Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)
CRC Press
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)
Springer
Immunotherapy of Cancer: Innovative Treatment Comes of Age
Springer
Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy: 1036 (Advances in Experimental Medicine and Biology, 1036)
Springer
Immunodiagnosis and Immunotherapy of Malignant Tumors: Relevance to Surgery
Springer
Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)
Humana
Elsevier Diagnostic Pathology: Molecular Oncology Reference
Elsevier
Immune-based Cancer Treatment: The T Iymphocyte Response
CRC Press
Critical Developments in Cancer Immunotherapy
A Beginner's Guide to Targeted Cancer Treatments
Wiley